Pharma Commercial Mock
← All views·CI feed·API docs
AASCO
Meeting Library
AACR Annual Meeting 2026 · San Diego, CA
200 shown of 9,342 total abstracts
  1. Abstract 90862026-04-04 · 16:15 CT · S100A
    Biomarker subgroup analysis of Opdivo in NSCLC (the CheckMate-861 study)
    F. Andre, S. Antonia · Peter MacCallum Cancer Centre
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  2. Abstract 93682026-04-02 · 15:30 CT · Hall B1
    Quality of life outcomes with Tagrisso in patients with NSCLC
    S. Tolaney, C. Saura, N. Rizvi, et al. · Princess Margaret Cancer Centre
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  3. Abstract 99052026-04-04 · 13:30 CT · S406
    Quality of life outcomes with Tecentriq in patients with NSCLC
    C. Robert, S. Antonia · University of Chicago
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  4. Abstract 92182026-04-05 · 16:45 CT · Hall B1
    Long-term follow-up of Tagrisso 2L for NSCLC: FLAURA-991
    H. Rugo, E. Winer, F. Andre, et al. · Mayo Clinic
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  5. Abstract 91242026-04-04 · 14:00 CT · S100A
    Quality of life outcomes with Opdivo in patients with NSCLC
    S. Tolaney, C. Robert, M.C. Garassino · Institut Gustave Roussy
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  6. Abstract 94662026-04-03 · 21:30 CT · Hall B1
    Imfinzi plus chemotherapy in previously untreated NSCLC: updated analysis from PACIFIC-44
    E. Winer, T. Mok · University of Chicago
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  7. Abstract 93082026-04-05 · 16:00 CT · Arie Crown Theater
    Long-term follow-up of Tagrisso 1L for NSCLC: FLAURA-644
    M. Reck, H. Rugo, R. Herbst · Memorial Sloan Kettering Cancer Center
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  8. Abstract 95662026-04-01 · 14:00 CT · S100A
    Biomarker subgroup analysis of Enhertu in NSCLC (the DESTINY-Breast-381 study)
    L. Paz-Ares, H. Borghaei, M. Krop, et al. · MD Anderson Cancer Center
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  9. Abstract 91612026-04-05 · 21:15 CT · E450
    PACIFIC-817: Imfinzi (durvalumab) adjuvant in SCLC
    H. Rugo, F. Andre, C. Saura, et al. · University of Chicago
    Poster SessionLung Cancer—Small Cell📄🖼️
  10. Abstract 91112026-04-05 · 16:45 CT · S100A
    Real-world effectiveness of Tagrisso vs standard of care in NSCLC
    A. Spira, S. Peters, J. Brahmer, et al. · MD Anderson Cancer Center
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  11. Abstract 93702026-04-03 · 20:45 CT · Arie Crown Theater
    Biomarker subgroup analysis of Imfinzi in SCLC (the PACIFIC-225 study)
    M.C. Garassino, S. Modi · Johns Hopkins Kimmel Cancer Center
    Poster SessionLung Cancer—Small Cell📄🖼️
  12. Abstract 92732026-04-01 · 18:15 CT · Arie Crown Theater
    FLAURA-650: Tagrisso (osimertinib) 2L in NSCLC
    J. Brahmer, A. Spira · Cleveland Clinic
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  13. Abstract 94292026-04-05 · 13:00 CT · Hall B1
    Quality of life outcomes with Enhertu in patients with NSCLC
    L. Paz-Ares, S. Peters, N. Rizvi, et al. · Chinese University of Hong Kong
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  14. Abstract 93292026-04-02 · 20:45 CT · Arie Crown Theater
    PACIFIC-337: Imfinzi (durvalumab) 2L in NSCLC
    H. Borghaei, L. Paz-Ares · Institut Gustave Roussy
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  15. Abstract 94612026-04-04 · 16:45 CT · Arie Crown Theater
    Imfinzi plus chemotherapy in previously untreated SCLC: updated analysis from PACIFIC-20
    E. Winer, A. Spira, C. Saura · Cleveland Clinic
    Poster SessionLung Cancer—Small Cell📄🖼️
  16. Abstract 91142026-04-05 · 15:45 CT · Arie Crown Theater
    Real-world effectiveness of Opdivo vs standard of care in NSCLC
    J. Brahmer, J. Cortes, N. Rizvi · University of Chicago
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  17. Abstract 93112026-04-02 · 14:45 CT · E450
    Biomarker subgroup analysis of Tagrisso in NSCLC (the FLAURA-951 study)
    T. Mok, H. Borghaei, M. Krop, et al. · Princess Margaret Cancer Centre
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  18. Abstract 96432026-04-04 · 19:45 CT · E450
    Tagrisso plus chemotherapy in previously untreated NSCLC: updated analysis from FLAURA-688
    T. Mok, A. Spira, F. Andre, et al. · UCSF Helen Diller Family Comprehensive Cancer Center
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  19. Abstract 99632026-04-01 · 21:15 CT · Arie Crown Theater
    Keytruda plus chemotherapy in previously untreated NSCLC: updated analysis from KEYNOTE-172
    S. Antonia, S. Modi, J. Cortes, et al. · Johns Hopkins Kimmel Cancer Center
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  20. Abstract 95762026-04-02 · 15:45 CT · S100A
    Real-world effectiveness of Keytruda vs standard of care in NSCLC
    A. Spira, J. Brahmer · Royal Marsden Hospital
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  21. Abstract 93152026-04-01 · 14:30 CT · E450
    Biomarker subgroup analysis of Tagrisso in NSCLC (the FLAURA-175 study)
    S. Antonia, L. Paz-Ares · National Cancer Center Japan
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  22. Abstract 93602026-04-03 · 21:30 CT · Hall B1
    Real-world effectiveness of Imfinzi vs standard of care in SCLC
    S. Tolaney, J. Cortes, J. Brahmer, et al. · National Cancer Center Japan
    Poster SessionLung Cancer—Small Cell📄🖼️
  23. Abstract 98222026-04-02 · 21:00 CT · Hall B1
    Long-term follow-up of Tagrisso adjuvant for NSCLC: FLAURA-13
    T. Mok, C. Saura · Institut Gustave Roussy
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  24. Abstract 92482026-04-01 · 18:00 CT · Arie Crown Theater
    PACIFIC-540: Imfinzi (durvalumab) 2L in SCLC
    M. Reck, S. Peters · Vall d'Hebron Institute of Oncology
    Poster SessionLung Cancer—Small Cell📄🖼️
  25. Abstract 99152026-04-03 · 20:30 CT · E450
    Quality of life outcomes with Imfinzi in patients with NSCLC
    L. Paz-Ares, H. Rugo, A. Spira, et al. · Royal Marsden Hospital
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  26. Abstract 90012026-04-05 · 20:30 CT · S100A
    Biomarker subgroup analysis of Imfinzi in SCLC (the PACIFIC-19 study)
    J. Cortes, E. Winer · Princess Margaret Cancer Centre
    Poster SessionLung Cancer—Small Cell📄🖼️
  27. Abstract 90722026-04-03 · 21:00 CT · Hall B1
    Quality of life outcomes with Keytruda in patients with SCLC
    R. Herbst, H. Rugo, J. Brahmer, et al. · Chinese University of Hong Kong
    Poster SessionLung Cancer—Small Cell📄🖼️
  28. Abstract 95472026-04-01 · 15:00 CT · S406
    Quality of life outcomes with Keytruda in patients with NSCLC
    J. Brahmer, C. Saura, S. Modi · Karolinska Institute
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  29. Abstract 92632026-04-02 · 19:15 CT · Arie Crown Theater
    Biomarker subgroup analysis of Imfinzi in NSCLC (the PACIFIC-186 study)
    H. Rugo, S. Antonia, A. Spira · Princess Margaret Cancer Centre
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  30. Abstract 97362026-04-01 · 15:45 CT · S100A
    Enhertu plus chemotherapy in previously untreated NSCLC: updated analysis from DESTINY-Breast-424
    S. Antonia, M. Reck · Mayo Clinic
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  31. Abstract 95352026-04-02 · 15:30 CT · S100A
    Enhertu plus chemotherapy in previously untreated NSCLC: updated analysis from DESTINY-Breast-863
    E. Winer, L. Paz-Ares, P. Schmid, et al. · UCSF Helen Diller Family Comprehensive Cancer Center
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  32. Abstract 91842026-04-05 · 14:45 CT · Arie Crown Theater
    Long-term follow-up of Imfinzi 2L for SCLC: PACIFIC-515
    S. Peters, J. Cortes, S. Modi · Dana-Farber Cancer Institute
    Poster SessionLung Cancer—Small Cell📄🖼️
  33. Abstract 93772026-04-04 · 19:45 CT · S406
    DESTINY-Breast-891: Enhertu (trastuzumab deruxtecan) 2L in NSCLC
    F. Andre, T. Mok, N. Rizvi, et al. · Dana-Farber Cancer Institute
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  34. Abstract 97092026-04-02 · 15:30 CT · E450
    KEYNOTE-250: Keytruda (pembrolizumab) 2L in NSCLC
    E. Winer, T. Mok, M.C. Garassino · Johns Hopkins Kimmel Cancer Center
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  35. Abstract 92122026-04-05 · 20:15 CT · E450
    Biomarker subgroup analysis of Imfinzi in NSCLC (the PACIFIC-247 study)
    E. Winer, S. Antonia, C. Robert · Massachusetts General Hospital
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  36. Abstract 94102026-04-01 · 15:30 CT · Hall B1
    Long-term follow-up of Tagrisso adjuvant for NSCLC: FLAURA-874
    M.C. Garassino, L. Paz-Ares, S. Antonia · Institut Gustave Roussy
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  37. Abstract 99432026-04-04 · 13:15 CT · Hall B1
    Long-term follow-up of Tagrisso neoadjuvant for NSCLC: FLAURA-939
    A. Spira, M. Reck · Karolinska Institute
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  38. Abstract 92242026-04-04 · 16:15 CT · E450
    CheckMate-107: Opdivo (nivolumab) 1L in NSCLC
    A. Spira, M. Krop · Stanford Cancer Institute
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  39. Abstract 99232026-04-04 · 15:30 CT · E450
    Long-term follow-up of Keytruda adjuvant for NSCLC: KEYNOTE-433
    J. Cortes, H. Rugo, M. Reck, et al. · Peter MacCallum Cancer Centre
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  40. Abstract 94702026-04-05 · 13:45 CT · Arie Crown Theater
    Tagrisso plus chemotherapy in previously untreated NSCLC: updated analysis from FLAURA-248
    C. Saura, G. Curigliano, L. Paz-Ares, et al. · Mayo Clinic
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  41. Abstract 95832026-04-02 · 15:30 CT · Arie Crown Theater
    Long-term follow-up of Opdivo 2L for NSCLC: CheckMate-919
    C. Saura, N. Rizvi, L. Paz-Ares, et al. · Johns Hopkins Kimmel Cancer Center
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  42. Abstract 95362026-04-01 · 19:45 CT · Hall B1
    Biomarker subgroup analysis of Tecentriq in NSCLC (the IMpower-667 study)
    A. Spira, H. Borghaei, C. Robert · University of Chicago
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  43. Abstract 91792026-04-03 · 18:30 CT · E450
    Real-world effectiveness of Keytruda vs standard of care in SCLC
    A. Spira, S. Peters, C. Robert, et al. · Karolinska Institute
    Poster SessionLung Cancer—Small Cell📄🖼️
  44. Abstract 93842026-04-04 · 15:00 CT · Hall B1
    Keytruda plus chemotherapy in previously untreated SCLC: updated analysis from KEYNOTE-265
    C. Robert, A. Spira, M.C. Garassino · Peter MacCallum Cancer Centre
    Poster SessionLung Cancer—Small Cell📄🖼️
  45. Abstract 93122026-04-01 · 21:15 CT · E450
    Real-world effectiveness of Imfinzi vs standard of care in NSCLC
    E. Winer, S. Modi · Mayo Clinic
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  46. Abstract 94642026-04-02 · 18:15 CT · Arie Crown Theater
    Biomarker subgroup analysis of Imfinzi in NSCLC (the PACIFIC-993 study)
    F. Andre, S. Tolaney, L. Paz-Ares, et al. · Vall d'Hebron Institute of Oncology
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  47. Abstract 98622026-04-03 · 21:45 CT · S406
    PACIFIC-794: Imfinzi (durvalumab) 1L in SCLC
    J. Cortes, S. Peters, F. Andre, et al. · Peter MacCallum Cancer Centre
    Poster SessionLung Cancer—Small Cell📄🖼️
  48. Abstract 99132026-04-04 · 16:15 CT · Hall B1
    FLAURA-131: Tagrisso (osimertinib) 3L+ in NSCLC
    P. Schmid, G. Curigliano · Chinese University of Hong Kong
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  49. Abstract 99372026-04-04 · 20:15 CT · E450
    Biomarker subgroup analysis of Tagrisso in NSCLC (the FLAURA-177 study)
    S. Antonia, L. Paz-Ares, R. Herbst · Vall d'Hebron Institute of Oncology
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  50. Abstract 92952026-04-04 · 15:00 CT · S100A
    PACIFIC-424: Imfinzi (durvalumab) maintenance in SCLC
    S. Antonia, L. Paz-Ares, M. Krop, et al. · Stanford Cancer Institute
    Poster SessionLung Cancer—Small Cell📄🖼️
  51. Abstract 91212026-04-01 · 13:15 CT · Arie Crown Theater
    Long-term follow-up of Keytruda 2L for SCLC: KEYNOTE-288
    M. Krop, L. Paz-Ares, N. Rizvi · Peter MacCallum Cancer Centre
    Poster SessionLung Cancer—Small Cell📄🖼️
  52. Abstract 96242026-04-05 · 20:15 CT · E450
    Biomarker subgroup analysis of Imfinzi in SCLC (the PACIFIC-47 study)
    E. Winer, A. Spira, C. Saura · National Cancer Center Japan
    Poster SessionLung Cancer—Small Cell📄🖼️
  53. Abstract 97102026-04-05 · 21:45 CT · S406
    Real-world effectiveness of Enhertu vs standard of care in NSCLC
    H. Rugo, M. Reck, R. Herbst · Mayo Clinic
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  54. Abstract 95952026-04-03 · 14:15 CT · S406
    Long-term follow-up of Tagrisso 2L for NSCLC: FLAURA-208
    S. Tolaney, N. Rizvi, M.C. Garassino, et al. · National Cancer Center Japan
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  55. Abstract 97182026-04-04 · 18:30 CT · E450
    Long-term follow-up of Keytruda 2L for SCLC: KEYNOTE-591
    P. Schmid, N. Rizvi, M.C. Garassino · Vall d'Hebron Institute of Oncology
    Poster SessionLung Cancer—Small Cell📄🖼️
  56. Abstract 94152026-04-02 · 20:45 CT · S406
    Biomarker subgroup analysis of Tagrisso in NSCLC (the FLAURA-290 study)
    M. Krop, T. Mok, S. Antonia, et al. · Institut Gustave Roussy
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  57. Abstract 90802026-04-04 · 13:00 CT · Hall B1
    Biomarker subgroup analysis of Tagrisso in NSCLC (the FLAURA-137 study)
    S. Peters, R. Herbst, P. Schmid, et al. · UCSF Helen Diller Family Comprehensive Cancer Center
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  58. Abstract 94002026-04-03 · 21:15 CT · S406
    PACIFIC-574: Imfinzi (durvalumab) neoadjuvant in SCLC
    A. Spira, J. Brahmer · MD Anderson Cancer Center
    Poster SessionLung Cancer—Small Cell📄🖼️
  59. Abstract 94682026-04-04 · 14:15 CT · E450
    Opdivo plus chemotherapy in previously untreated NSCLC: updated analysis from CheckMate-629
    E. Winer, L. Paz-Ares, M.C. Garassino · Mayo Clinic
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  60. Abstract 94662026-04-01 · 15:00 CT · Arie Crown Theater
    Imfinzi plus chemotherapy in previously untreated NSCLC: updated analysis from PACIFIC-435
    J. Cortes, N. Rizvi, H. Borghaei, et al. · Memorial Sloan Kettering Cancer Center
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  61. Abstract 93442026-04-02 · 14:00 CT · Hall B1
    Biomarker subgroup analysis of Tecentriq in NSCLC (the IMpower-585 study)
    A. Spira, M. Reck · National Cancer Center Japan
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  62. Abstract 96612026-04-02 · 13:30 CT · E450
    Biomarker subgroup analysis of Keytruda in NSCLC (the KEYNOTE-60 study)
    L. Paz-Ares, H. Borghaei · Chinese University of Hong Kong
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  63. Abstract 99482026-04-03 · 16:45 CT · Hall B1
    Long-term follow-up of Imfinzi 1L for SCLC: PACIFIC-517
    J. Brahmer, H. Rugo, S. Modi · Stanford Cancer Institute
    Poster SessionLung Cancer—Small Cell📄🖼️
  64. Abstract 98082026-04-04 · 19:00 CT · S100A
    Tagrisso plus chemotherapy in previously untreated NSCLC: updated analysis from FLAURA-159
    F. Andre, S. Antonia, L. Paz-Ares, et al. · MD Anderson Cancer Center
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  65. Abstract 97272026-04-05 · 16:30 CT · Arie Crown Theater
    PACIFIC-193: Imfinzi (durvalumab) adjuvant in SCLC
    L. Paz-Ares, F. Andre, T. Mok, et al. · Stanford Cancer Institute
    Poster SessionLung Cancer—Small Cell📄🖼️
  66. Abstract 90032026-04-03 · 21:30 CT · S100A
    Long-term follow-up of Tecentriq maintenance for NSCLC: IMpower-372
    A. Spira, F. Andre, S. Peters · Princess Margaret Cancer Centre
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  67. Abstract 98542026-04-04 · 16:00 CT · S406
    Biomarker subgroup analysis of Keytruda in NSCLC (the KEYNOTE-209 study)
    A. Spira, C. Robert, H. Borghaei · Dana-Farber Cancer Institute
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  68. Abstract 92462026-04-03 · 19:45 CT · Hall B1
    Long-term follow-up of Tecentriq neoadjuvant for NSCLC: IMpower-369
    C. Saura, M. Reck, J. Brahmer, et al. · Memorial Sloan Kettering Cancer Center
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  69. Abstract 94912026-04-01 · 15:45 CT · S100A
    Tagrisso plus chemotherapy in previously untreated NSCLC: updated analysis from FLAURA-830
    J. Cortes, C. Saura, S. Antonia, et al. · Institut Gustave Roussy
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  70. Abstract 95332026-04-03 · 14:30 CT · S100A
    Enhertu plus chemotherapy in previously untreated NSCLC: updated analysis from DESTINY-Breast-95
    M. Krop, P. Schmid, H. Borghaei, et al. · Peter MacCallum Cancer Centre
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  71. Abstract 92552026-04-04 · 13:00 CT · S406
    Long-term follow-up of Opdivo adjuvant for NSCLC: CheckMate-312
    S. Antonia, M. Krop · Princess Margaret Cancer Centre
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  72. Abstract 97632026-04-04 · 15:45 CT · S100A
    Tagrisso plus chemotherapy in previously untreated NSCLC: updated analysis from FLAURA-436
    R. Herbst, M. Krop · Institut Gustave Roussy
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  73. Abstract 95632026-04-02 · 19:30 CT · E450
    Imfinzi plus chemotherapy in previously untreated SCLC: updated analysis from PACIFIC-874
    C. Robert, J. Cortes, M. Reck, et al. · Stanford Cancer Institute
    Poster SessionLung Cancer—Small Cell📄🖼️
  74. Abstract 98582026-04-03 · 18:00 CT · S100A
    Real-world effectiveness of Tecentriq vs standard of care in NSCLC
    A. Spira, H. Rugo · Vall d'Hebron Institute of Oncology
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  75. Abstract 97592026-04-01 · 14:00 CT · Hall B1
    Biomarker subgroup analysis of Tagrisso in NSCLC (the FLAURA-444 study)
    J. Brahmer, F. Andre · Chinese University of Hong Kong
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  76. Abstract 96982026-04-01 · 13:15 CT · S100A
    Imfinzi plus chemotherapy in previously untreated SCLC: updated analysis from PACIFIC-112
    M.C. Garassino, A. Spira, S. Peters, et al. · National Cancer Center Japan
    Poster SessionLung Cancer—Small Cell📄🖼️
  77. Abstract 90602026-04-04 · 21:15 CT · S406
    Biomarker subgroup analysis of Tagrisso in NSCLC (the FLAURA-933 study)
    P. Schmid, J. Brahmer, T. Mok, et al. · Mayo Clinic
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  78. Abstract 97292026-04-03 · 21:00 CT · Arie Crown Theater
    Long-term follow-up of Tecentriq maintenance for NSCLC: IMpower-909
    M. Krop, S. Peters, L. Paz-Ares · Chinese University of Hong Kong
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  79. Abstract 95152026-04-02 · 14:30 CT · S100A
    PACIFIC-240: Imfinzi (durvalumab) adjuvant in SCLC
    S. Peters, H. Rugo, F. Andre, et al. · University of Chicago
    Poster SessionLung Cancer—Small Cell📄🖼️
  80. Abstract 94052026-04-01 · 15:00 CT · S100A
    Enhertu plus chemotherapy in previously untreated NSCLC: updated analysis from DESTINY-Breast-397
    A. Spira, M. Reck, R. Herbst, et al. · National Cancer Center Japan
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  81. Abstract 98982026-04-05 · 15:00 CT · S406
    IMpower-794: Tecentriq (atezolizumab) 2L in NSCLC
    E. Winer, L. Paz-Ares · Cleveland Clinic
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  82. Abstract 93632026-04-01 · 15:15 CT · S406
    Tagrisso plus chemotherapy in previously untreated NSCLC: updated analysis from FLAURA-756
    C. Robert, H. Borghaei · Cleveland Clinic
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  83. Abstract 94502026-04-03 · 20:30 CT · S406
    Enhertu plus chemotherapy in previously untreated NSCLC: updated analysis from DESTINY-Breast-429
    J. Brahmer, R. Herbst, C. Robert, et al. · Mayo Clinic
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  84. Abstract 99822026-04-04 · 15:00 CT · S100A
    PACIFIC-653: Imfinzi (durvalumab) 1L in SCLC
    H. Rugo, M.C. Garassino, T. Mok · Chinese University of Hong Kong
    Poster SessionLung Cancer—Small Cell📄🖼️
  85. Abstract 98552026-04-05 · 18:45 CT · Arie Crown Theater
    IMpower-46: Tecentriq (atezolizumab) 1L in NSCLC
    G. Curigliano, H. Borghaei, P. Schmid · Princess Margaret Cancer Centre
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  86. Abstract 90302026-04-04 · 21:00 CT · S100A
    DESTINY-Breast-158: Enhertu (trastuzumab deruxtecan) 2L in NSCLC
    N. Rizvi, M. Krop · Johns Hopkins Kimmel Cancer Center
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  87. Abstract 97922026-04-03 · 13:15 CT · E450
    Biomarker subgroup analysis of Imfinzi in NSCLC (the PACIFIC-382 study)
    S. Modi, M.C. Garassino, H. Rugo · Mayo Clinic
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  88. Abstract 99012026-04-05 · 21:15 CT · Hall B1
    Long-term follow-up of Tagrisso 3L+ for NSCLC: FLAURA-848
    E. Winer, M. Reck, G. Curigliano · University of Chicago
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  89. Abstract 93852026-04-03 · 15:15 CT · S100A
    Tecentriq plus chemotherapy in previously untreated NSCLC: updated analysis from IMpower-852
    F. Andre, S. Tolaney, S. Peters · Cleveland Clinic
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  90. Abstract 92172026-04-05 · 15:00 CT · S406
    Biomarker subgroup analysis of Keytruda in SCLC (the KEYNOTE-83 study)
    E. Winer, H. Borghaei, M.C. Garassino, et al. · UCSF Helen Diller Family Comprehensive Cancer Center
    Poster SessionLung Cancer—Small Cell📄🖼️
  91. Abstract 97142026-04-03 · 18:30 CT · S406
    Biomarker subgroup analysis of Keytruda in SCLC (the KEYNOTE-709 study)
    H. Rugo, L. Paz-Ares · Cleveland Clinic
    Poster SessionLung Cancer—Small Cell📄🖼️
  92. Abstract 91732026-04-01 · 18:15 CT · Hall B1
    KEYNOTE-552: Keytruda (pembrolizumab) neoadjuvant in SCLC
    M.C. Garassino, A. Spira · Mayo Clinic
    Poster SessionLung Cancer—Small Cell📄🖼️
  93. Abstract 99852026-04-02 · 16:45 CT · Arie Crown Theater
    Imfinzi plus chemotherapy in previously untreated NSCLC: updated analysis from PACIFIC-569
    S. Antonia, H. Borghaei · Dana-Farber Cancer Institute
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  94. Abstract 92092026-04-02 · 16:30 CT · Hall B1
    Tagrisso plus chemotherapy in previously untreated NSCLC: updated analysis from FLAURA-531
    S. Peters, S. Modi · Chinese University of Hong Kong
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  95. Abstract 96152026-04-05 · 21:15 CT · S100A
    Long-term follow-up of Keytruda 1L for NSCLC: KEYNOTE-255
    R. Herbst, N. Rizvi · UCSF Helen Diller Family Comprehensive Cancer Center
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  96. Abstract 91902026-04-02 · 20:15 CT · Arie Crown Theater
    PACIFIC-274: Imfinzi (durvalumab) maintenance in NSCLC
    M. Krop, P. Schmid, G. Curigliano · Karolinska Institute
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  97. Abstract 95782026-04-01 · 21:00 CT · Arie Crown Theater
    DESTINY-Breast-446: Enhertu (trastuzumab deruxtecan) neoadjuvant in NSCLC
    M.C. Garassino, S. Peters, C. Robert, et al. · Stanford Cancer Institute
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  98. Abstract 94762026-04-05 · 13:30 CT · S406
    FLAURA-708: Tagrisso (osimertinib) adjuvant in NSCLC
    C. Robert, M. Krop, S. Modi, et al. · Dana-Farber Cancer Institute
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  99. Abstract 93262026-04-03 · 16:00 CT · E450
    KEYNOTE-415: Keytruda (pembrolizumab) 1L in NSCLC
    H. Rugo, N. Rizvi · Vall d'Hebron Institute of Oncology
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  100. Abstract 98592026-04-03 · 21:15 CT · Arie Crown Theater
    FLAURA-677: Tagrisso (osimertinib) maintenance in NSCLC
    M. Krop, M. Reck, J. Cortes, et al. · Royal Marsden Hospital
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  101. Abstract 93132026-04-02 · 21:30 CT · S406
    FLAURA-509: Tagrisso (osimertinib) maintenance in NSCLC
    S. Antonia, M.C. Garassino, M. Reck · Vall d'Hebron Institute of Oncology
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  102. Abstract 90002026-04-01 · 14:45 CT · Arie Crown Theater
    Long-term follow-up of Keytruda maintenance for NSCLC: KEYNOTE-683
    S. Peters, S. Antonia · MD Anderson Cancer Center
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  103. Abstract 95232026-04-02 · 16:45 CT · S100A
    FLAURA-23: Tagrisso (osimertinib) 1L in NSCLC
    E. Winer, L. Paz-Ares · National Cancer Center Japan
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  104. Abstract 92682026-04-02 · 21:45 CT · E450
    Long-term follow-up of Tecentriq maintenance for NSCLC: IMpower-361
    S. Peters, N. Rizvi · Princess Margaret Cancer Centre
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  105. Abstract 94142026-04-01 · 18:15 CT · Arie Crown Theater
    Biomarker subgroup analysis of Tagrisso in NSCLC (the FLAURA-396 study)
    S. Antonia, J. Cortes, C. Robert, et al. · Institut Gustave Roussy
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  106. Abstract 94432026-04-05 · 14:15 CT · Hall B1
    Biomarker subgroup analysis of Imfinzi in SCLC (the PACIFIC-644 study)
    E. Winer, T. Mok · Massachusetts General Hospital
    Poster SessionLung Cancer—Small Cell📄🖼️
  107. Abstract 94922026-04-01 · 19:15 CT · E450
    Keytruda plus chemotherapy in previously untreated NSCLC: updated analysis from KEYNOTE-834
    M. Krop, A. Spira, S. Peters · Karolinska Institute
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  108. Abstract 90312026-04-01 · 20:30 CT · Arie Crown Theater
    Biomarker subgroup analysis of Keytruda in NSCLC (the KEYNOTE-889 study)
    L. Paz-Ares, G. Curigliano, H. Rugo · Vall d'Hebron Institute of Oncology
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  109. Abstract 97652026-04-05 · 13:00 CT · Arie Crown Theater
    FLAURA-603: Tagrisso (osimertinib) 2L in NSCLC
    J. Brahmer, S. Modi, L. Paz-Ares, et al. · Peter MacCallum Cancer Centre
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  110. Abstract 97492026-04-01 · 15:00 CT · S100A
    PACIFIC-699: Imfinzi (durvalumab) neoadjuvant in SCLC
    R. Herbst, S. Modi, N. Rizvi, et al. · Johns Hopkins Kimmel Cancer Center
    Poster SessionLung Cancer—Small Cell📄🖼️
  111. Abstract 97912026-04-03 · 18:15 CT · Hall B1
    Long-term follow-up of Tecentriq adjuvant for NSCLC: IMpower-216
    M. Krop, S. Tolaney · Memorial Sloan Kettering Cancer Center
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  112. Abstract 99992026-04-01 · 21:00 CT · Hall B1
    Long-term follow-up of Tagrisso neoadjuvant for NSCLC: FLAURA-50
    R. Herbst, M. Reck, T. Mok, et al. · Vall d'Hebron Institute of Oncology
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  113. Abstract 90912026-04-01 · 14:30 CT · E450
    PACIFIC-72: Imfinzi (durvalumab) 1L in SCLC
    F. Andre, A. Spira, G. Curigliano, et al. · Memorial Sloan Kettering Cancer Center
    Poster SessionLung Cancer—Small Cell📄🖼️
  114. Abstract 93162026-04-04 · 13:30 CT · Hall B1
    Long-term follow-up of Imfinzi 2L for NSCLC: PACIFIC-377
    G. Curigliano, S. Modi, L. Paz-Ares · Princess Margaret Cancer Centre
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  115. Abstract 95782026-04-04 · 16:00 CT · E450
    Long-term follow-up of Tagrisso 3L+ for NSCLC: FLAURA-572
    G. Curigliano, A. Spira, M.C. Garassino · Peter MacCallum Cancer Centre
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  116. Abstract 94842026-04-02 · 20:00 CT · S100A
    Tecentriq plus chemotherapy in previously untreated NSCLC: updated analysis from IMpower-641
    C. Robert, S. Tolaney, H. Borghaei, et al. · Peter MacCallum Cancer Centre
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  117. Abstract 91132026-04-04 · 15:00 CT · S406
    Long-term follow-up of Imfinzi 3L+ for NSCLC: PACIFIC-939
    J. Brahmer, E. Winer · University of Chicago
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  118. Abstract 92452026-04-02 · 14:00 CT · E450
    Long-term follow-up of Tagrisso maintenance for NSCLC: FLAURA-840
    S. Peters, J. Cortes, T. Mok, et al. · Vall d'Hebron Institute of Oncology
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  119. Abstract 95172026-04-03 · 14:30 CT · Hall B1
    Long-term follow-up of Keytruda maintenance for NSCLC: KEYNOTE-307
    M.C. Garassino, M. Reck, S. Modi · Peter MacCallum Cancer Centre
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  120. Abstract 91032026-04-01 · 21:30 CT · Arie Crown Theater
    Biomarker subgroup analysis of Tagrisso in NSCLC (the FLAURA-979 study)
    J. Brahmer, T. Mok, P. Schmid · UCSF Helen Diller Family Comprehensive Cancer Center
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  121. Abstract 99382026-04-03 · 21:15 CT · Arie Crown Theater
    DESTINY-Breast-952: Enhertu (trastuzumab deruxtecan) maintenance in NSCLC
    L. Paz-Ares, J. Brahmer, R. Herbst, et al. · Vall d'Hebron Institute of Oncology
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  122. Abstract 93922026-04-03 · 13:30 CT · Hall B1
    Keytruda plus chemotherapy in previously untreated SCLC: updated analysis from KEYNOTE-749
    S. Tolaney, M. Reck, J. Brahmer, et al. · Dana-Farber Cancer Institute
    Poster SessionLung Cancer—Small Cell📄🖼️
  123. Abstract 98842026-04-02 · 19:45 CT · Hall B1
    Biomarker subgroup analysis of Opdivo in NSCLC (the CheckMate-604 study)
    S. Peters, H. Borghaei · Massachusetts General Hospital
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  124. Abstract 93722026-04-03 · 20:45 CT · Arie Crown Theater
    Long-term follow-up of Tagrisso 1L for NSCLC: FLAURA-346
    H. Rugo, S. Antonia, A. Spira, et al. · Cleveland Clinic
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  125. Abstract 98192026-04-01 · 19:45 CT · Hall B1
    Biomarker subgroup analysis of Imfinzi in NSCLC (the PACIFIC-435 study)
    J. Cortes, S. Peters, J. Brahmer, et al. · Karolinska Institute
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  126. Abstract 91532026-04-02 · 21:15 CT · S100A
    Biomarker subgroup analysis of Imfinzi in NSCLC (the PACIFIC-196 study)
    J. Brahmer, H. Borghaei, S. Modi, et al. · Institut Gustave Roussy
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  127. Abstract 98222026-04-01 · 13:15 CT · S100A
    Long-term follow-up of Opdivo 2L for NSCLC: CheckMate-148
    C. Saura, L. Paz-Ares, N. Rizvi, et al. · Memorial Sloan Kettering Cancer Center
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  128. Abstract 94322026-04-05 · 13:15 CT · S100A
    Biomarker subgroup analysis of Imfinzi in NSCLC (the PACIFIC-288 study)
    N. Rizvi, S. Peters · Dana-Farber Cancer Institute
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  129. Abstract 91332026-04-02 · 14:15 CT · Hall B1
    KEYNOTE-350: Keytruda (pembrolizumab) adjuvant in SCLC
    H. Rugo, L. Paz-Ares · Karolinska Institute
    Poster SessionLung Cancer—Small Cell📄🖼️
  130. Abstract 99082026-04-05 · 18:00 CT · E450
    Biomarker subgroup analysis of Tagrisso in NSCLC (the FLAURA-928 study)
    J. Cortes, P. Schmid, S. Modi, et al. · Memorial Sloan Kettering Cancer Center
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  131. Abstract 90982026-04-04 · 13:00 CT · Hall B1
    Long-term follow-up of Tecentriq adjuvant for NSCLC: IMpower-698
    S. Antonia, A. Spira, C. Saura, et al. · Princess Margaret Cancer Centre
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  132. Abstract 91962026-04-03 · 13:00 CT · Arie Crown Theater
    Imfinzi plus chemotherapy in previously untreated SCLC: updated analysis from PACIFIC-526
    H. Rugo, F. Andre, S. Antonia, et al. · Mayo Clinic
    Poster SessionLung Cancer—Small Cell📄🖼️
  133. Abstract 93612026-04-05 · 20:45 CT · S100A
    FLAURA-63: Tagrisso (osimertinib) maintenance in NSCLC
    P. Schmid, R. Herbst, H. Rugo, et al. · National Cancer Center Japan
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  134. Abstract 96862026-04-02 · 15:45 CT · S100A
    Tagrisso plus chemotherapy in previously untreated NSCLC: updated analysis from FLAURA-766
    H. Borghaei, M. Krop, H. Rugo, et al. · Chinese University of Hong Kong
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  135. Abstract 94762026-04-03 · 16:15 CT · Arie Crown Theater
    Long-term follow-up of Tagrisso maintenance for NSCLC: FLAURA-89
    S. Antonia, S. Tolaney · Mayo Clinic
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  136. Abstract 99862026-04-04 · 18:00 CT · Hall B1
    Tagrisso plus chemotherapy in previously untreated NSCLC: updated analysis from FLAURA-133
    T. Mok, L. Paz-Ares, E. Winer, et al. · Cleveland Clinic
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  137. Abstract 97052026-04-04 · 21:30 CT · S100A
    Opdivo plus chemotherapy in previously untreated NSCLC: updated analysis from CheckMate-393
    M. Reck, L. Paz-Ares, N. Rizvi, et al. · Karolinska Institute
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  138. Abstract 92632026-04-01 · 14:15 CT · Arie Crown Theater
    Biomarker subgroup analysis of Opdivo in NSCLC (the CheckMate-160 study)
    S. Tolaney, C. Saura, F. Andre, et al. · Dana-Farber Cancer Institute
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  139. Abstract 99102026-04-02 · 13:15 CT · S100A
    Long-term follow-up of Imfinzi maintenance for SCLC: PACIFIC-193
    E. Winer, M. Reck, H. Borghaei, et al. · UCSF Helen Diller Family Comprehensive Cancer Center
    Poster SessionLung Cancer—Small Cell📄🖼️
  140. Abstract 94172026-04-02 · 19:15 CT · E450
    Tagrisso plus chemotherapy in previously untreated NSCLC: updated analysis from FLAURA-395
    P. Schmid, S. Peters, L. Paz-Ares, et al. · MD Anderson Cancer Center
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  141. Abstract 93362026-04-05 · 20:15 CT · S406
    Biomarker subgroup analysis of Tagrisso in NSCLC (the FLAURA-899 study)
    N. Rizvi, P. Schmid, S. Antonia, et al. · Johns Hopkins Kimmel Cancer Center
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  142. Abstract 93912026-04-05 · 20:30 CT · Arie Crown Theater
    Biomarker subgroup analysis of Keytruda in SCLC (the KEYNOTE-103 study)
    T. Mok, M. Krop, A. Spira · MD Anderson Cancer Center
    Poster SessionLung Cancer—Small Cell📄🖼️
  143. Abstract 94382026-04-05 · 20:00 CT · Hall B1
    Long-term follow-up of Tagrisso maintenance for NSCLC: FLAURA-846
    F. Andre, M. Reck, H. Borghaei · Vall d'Hebron Institute of Oncology
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  144. Abstract 93962026-04-02 · 14:30 CT · S406
    PACIFIC-65: Imfinzi (durvalumab) adjuvant in NSCLC
    P. Schmid, E. Winer, J. Brahmer, et al. · Memorial Sloan Kettering Cancer Center
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  145. Abstract 90932026-04-05 · 14:45 CT · E450
    Opdivo plus chemotherapy in previously untreated NSCLC: updated analysis from CheckMate-897
    M. Krop, T. Mok, P. Schmid · Princess Margaret Cancer Centre
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  146. Abstract 98742026-04-04 · 18:45 CT · Arie Crown Theater
    Long-term follow-up of Enhertu 1L for NSCLC: DESTINY-Breast-820
    F. Andre, H. Borghaei, H. Rugo · Dana-Farber Cancer Institute
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  147. Abstract 94872026-04-01 · 18:00 CT · S406
    Biomarker subgroup analysis of Imfinzi in NSCLC (the PACIFIC-371 study)
    M. Reck, C. Robert, H. Borghaei · Cleveland Clinic
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  148. Abstract 95362026-04-05 · 21:15 CT · S406
    FLAURA-602: Tagrisso (osimertinib) neoadjuvant in NSCLC
    C. Robert, N. Rizvi · Karolinska Institute
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  149. Abstract 91422026-04-03 · 19:00 CT · Arie Crown Theater
    Biomarker subgroup analysis of Tagrisso in NSCLC (the FLAURA-158 study)
    C. Robert, M. Reck, G. Curigliano · Vall d'Hebron Institute of Oncology
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  150. Abstract 98782026-04-04 · 15:30 CT · S406
    Biomarker subgroup analysis of Imfinzi in SCLC (the PACIFIC-470 study)
    P. Schmid, H. Borghaei, J. Brahmer, et al. · National Cancer Center Japan
    Poster SessionLung Cancer—Small Cell📄🖼️
  151. Abstract 95422026-04-05 · 19:15 CT · S100A
    DESTINY-Breast-734: Enhertu (trastuzumab deruxtecan) 3L+ in NSCLC
    J. Cortes, G. Curigliano · Vall d'Hebron Institute of Oncology
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  152. Abstract 97752026-04-01 · 19:45 CT · S100A
    Imfinzi plus chemotherapy in previously untreated SCLC: updated analysis from PACIFIC-934
    J. Brahmer, F. Andre · Stanford Cancer Institute
    Poster SessionLung Cancer—Small Cell📄🖼️
  153. Abstract 99532026-04-05 · 14:45 CT · Hall B1
    Tagrisso plus chemotherapy in previously untreated NSCLC: updated analysis from FLAURA-463
    L. Paz-Ares, S. Tolaney, P. Schmid · University of Chicago
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  154. Abstract 96402026-04-03 · 20:30 CT · S406
    FLAURA-194: Tagrisso (osimertinib) 3L+ in NSCLC
    A. Spira, M. Krop, N. Rizvi, et al. · Johns Hopkins Kimmel Cancer Center
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  155. Abstract 92432026-04-03 · 13:45 CT · S100A
    Biomarker subgroup analysis of Opdivo in NSCLC (the CheckMate-968 study)
    F. Andre, C. Robert, L. Paz-Ares, et al. · Massachusetts General Hospital
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  156. Abstract 97442026-04-03 · 16:45 CT · E450
    Enhertu plus chemotherapy in previously untreated NSCLC: updated analysis from DESTINY-Breast-235
    S. Peters, M. Krop, M. Reck, et al. · Karolinska Institute
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  157. Abstract 96892026-04-01 · 13:15 CT · S100A
    Imfinzi plus chemotherapy in previously untreated NSCLC: updated analysis from PACIFIC-207
    S. Tolaney, J. Brahmer, A. Spira · Princess Margaret Cancer Centre
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  158. Abstract 95132026-04-05 · 20:15 CT · S406
    Opdivo plus chemotherapy in previously untreated NSCLC: updated analysis from CheckMate-471
    C. Saura, S. Peters, N. Rizvi, et al. · Royal Marsden Hospital
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  159. Abstract 90792026-04-04 · 20:45 CT · S406
    Biomarker subgroup analysis of Enhertu in NSCLC (the DESTINY-Breast-964 study)
    S. Tolaney, M. Reck, S. Antonia, et al. · UCSF Helen Diller Family Comprehensive Cancer Center
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  160. Abstract 95822026-04-05 · 16:45 CT · S406
    Biomarker subgroup analysis of Keytruda in SCLC (the KEYNOTE-667 study)
    T. Mok, J. Brahmer, M.C. Garassino, et al. · MD Anderson Cancer Center
    Poster SessionLung Cancer—Small Cell📄🖼️
  161. Abstract 98032026-04-02 · 14:15 CT · S406
    Biomarker subgroup analysis of Tagrisso in NSCLC (the FLAURA-939 study)
    M. Krop, M.C. Garassino, R. Herbst · Mayo Clinic
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  162. Abstract 96302026-04-05 · 14:00 CT · S100A
    Biomarker subgroup analysis of Imfinzi in SCLC (the PACIFIC-484 study)
    T. Mok, S. Tolaney, N. Rizvi · Massachusetts General Hospital
    Poster SessionLung Cancer—Small Cell📄🖼️
  163. Abstract 91172026-04-02 · 16:00 CT · Hall B1
    Long-term follow-up of Tagrisso 1L for NSCLC: FLAURA-227
    C. Saura, J. Cortes, M. Krop, et al. · Peter MacCallum Cancer Centre
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  164. Abstract 91882026-04-03 · 14:30 CT · S100A
    Tagrisso plus chemotherapy in previously untreated NSCLC: updated analysis from FLAURA-971
    R. Herbst, S. Peters, M.C. Garassino · Cleveland Clinic
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  165. Abstract 96952026-04-04 · 16:15 CT · E450
    Imfinzi plus chemotherapy in previously untreated NSCLC: updated analysis from PACIFIC-831
    M. Reck, T. Mok, M. Krop, et al. · Johns Hopkins Kimmel Cancer Center
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  166. Abstract 97052026-04-02 · 19:45 CT · Arie Crown Theater
    Enhertu plus chemotherapy in previously untreated NSCLC: updated analysis from DESTINY-Breast-671
    T. Mok, F. Andre, P. Schmid, et al. · Chinese University of Hong Kong
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  167. Abstract 97992026-04-04 · 20:15 CT · S100A
    Biomarker subgroup analysis of Tagrisso in NSCLC (the FLAURA-514 study)
    J. Brahmer, T. Mok, S. Tolaney, et al. · Vall d'Hebron Institute of Oncology
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  168. Abstract 98782026-04-03 · 15:15 CT · Arie Crown Theater
    Imfinzi plus chemotherapy in previously untreated NSCLC: updated analysis from PACIFIC-709
    A. Spira, F. Andre · Mayo Clinic
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  169. Abstract 99812026-04-03 · 13:45 CT · Arie Crown Theater
    Long-term follow-up of Opdivo 3L+ for NSCLC: CheckMate-390
    G. Curigliano, S. Antonia, S. Tolaney, et al. · Royal Marsden Hospital
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  170. Abstract 93182026-04-03 · 19:15 CT · Hall B1
    KEYNOTE-114: Keytruda (pembrolizumab) 2L in NSCLC
    C. Saura, S. Peters, N. Rizvi, et al. · University of Chicago
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  171. Abstract 96372026-04-04 · 14:00 CT · Hall B1
    Keytruda plus chemotherapy in previously untreated SCLC: updated analysis from KEYNOTE-664
    S. Modi, N. Rizvi, R. Herbst · National Cancer Center Japan
    Poster SessionLung Cancer—Small Cell📄🖼️
  172. Abstract 96932026-04-01 · 13:45 CT · Hall B1
    Quality of life outcomes with Imfinzi in patients with SCLC
    E. Winer, G. Curigliano, L. Paz-Ares, et al. · Stanford Cancer Institute
    Poster SessionLung Cancer—Small Cell📄🖼️
  173. Abstract 97232026-04-05 · 16:00 CT · Arie Crown Theater
    Tecentriq plus chemotherapy in previously untreated NSCLC: updated analysis from IMpower-601
    H. Rugo, N. Rizvi, F. Andre · Chinese University of Hong Kong
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  174. Abstract 92452026-04-04 · 15:45 CT · S406
    Imfinzi plus chemotherapy in previously untreated NSCLC: updated analysis from PACIFIC-747
    S. Tolaney, M.C. Garassino, C. Saura, et al. · Princess Margaret Cancer Centre
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  175. Abstract 94752026-04-02 · 21:45 CT · Arie Crown Theater
    PACIFIC-386: Imfinzi (durvalumab) adjuvant in NSCLC
    G. Curigliano, P. Schmid, T. Mok, et al. · National Cancer Center Japan
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  176. Abstract 98442026-04-02 · 14:15 CT · S406
    FLAURA-474: Tagrisso (osimertinib) 1L in NSCLC
    J. Cortes, J. Brahmer, E. Winer, et al. · Vall d'Hebron Institute of Oncology
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  177. Abstract 97902026-04-05 · 14:00 CT · S406
    FLAURA-304: Tagrisso (osimertinib) neoadjuvant in NSCLC
    F. Andre, S. Peters, A. Spira, et al. · Chinese University of Hong Kong
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  178. Abstract 95932026-04-01 · 19:15 CT · E450
    KEYNOTE-11: Keytruda (pembrolizumab) maintenance in SCLC
    H. Borghaei, S. Peters, S. Tolaney, et al. · Mayo Clinic
    Poster SessionLung Cancer—Small Cell📄🖼️
  179. Abstract 98422026-04-01 · 14:30 CT · S406
    Long-term follow-up of Tagrisso 3L+ for NSCLC: FLAURA-568
    S. Antonia, S. Peters, C. Robert, et al. · Cleveland Clinic
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  180. Abstract 98682026-04-04 · 21:15 CT · S100A
    Long-term follow-up of Tagrisso neoadjuvant for NSCLC: FLAURA-465
    J. Cortes, J. Brahmer, F. Andre, et al. · Vall d'Hebron Institute of Oncology
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  181. Abstract 92732026-04-01 · 16:30 CT · E450
    Long-term follow-up of Keytruda neoadjuvant for NSCLC: KEYNOTE-520
    E. Winer, F. Andre, C. Robert, et al. · UCSF Helen Diller Family Comprehensive Cancer Center
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  182. Abstract 99122026-04-03 · 13:30 CT · E450
    Enhertu plus chemotherapy in previously untreated NSCLC: updated analysis from DESTINY-Breast-836
    L. Paz-Ares, G. Curigliano · Princess Margaret Cancer Centre
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  183. Abstract 93582026-04-02 · 14:30 CT · E450
    Biomarker subgroup analysis of Tecentriq in NSCLC (the IMpower-195 study)
    C. Robert, J. Brahmer, A. Spira, et al. · Institut Gustave Roussy
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  184. Abstract 98922026-04-04 · 15:15 CT · S100A
    Long-term follow-up of Tecentriq neoadjuvant for NSCLC: IMpower-744
    H. Rugo, T. Mok, H. Borghaei, et al. · Cleveland Clinic
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  185. Abstract 97482026-04-02 · 21:15 CT · E450
    Biomarker subgroup analysis of Tagrisso in NSCLC (the FLAURA-437 study)
    N. Rizvi, L. Paz-Ares, S. Modi · Karolinska Institute
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  186. Abstract 90372026-04-05 · 20:45 CT · Arie Crown Theater
    Long-term follow-up of Imfinzi adjuvant for SCLC: PACIFIC-314
    H. Borghaei, P. Schmid, S. Antonia, et al. · Chinese University of Hong Kong
    Poster SessionLung Cancer—Small Cell📄🖼️
  187. Abstract 91432026-04-04 · 20:30 CT · S100A
    Long-term follow-up of Tagrisso maintenance for NSCLC: FLAURA-893
    H. Borghaei, L. Paz-Ares · Karolinska Institute
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  188. Abstract 93222026-04-02 · 21:30 CT · E450
    Tagrisso plus chemotherapy in previously untreated NSCLC: updated analysis from FLAURA-890
    G. Curigliano, M.C. Garassino, J. Cortes, et al. · Dana-Farber Cancer Institute
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  189. Abstract 99232026-04-03 · 20:45 CT · E450
    Opdivo plus chemotherapy in previously untreated NSCLC: updated analysis from CheckMate-891
    N. Rizvi, S. Antonia, T. Mok, et al. · Stanford Cancer Institute
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  190. Abstract 94752026-04-04 · 14:45 CT · E450
    Biomarker subgroup analysis of Tecentriq in NSCLC (the IMpower-74 study)
    J. Cortes, H. Rugo, S. Antonia · Chinese University of Hong Kong
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  191. Abstract 92982026-04-02 · 19:00 CT · S100A
    Enhertu plus chemotherapy in previously untreated NSCLC: updated analysis from DESTINY-Breast-279
    G. Curigliano, L. Paz-Ares, C. Saura · Massachusetts General Hospital
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  192. Abstract 94002026-04-05 · 13:45 CT · E450
    Long-term follow-up of Tagrisso neoadjuvant for NSCLC: FLAURA-679
    H. Borghaei, J. Brahmer · Vall d'Hebron Institute of Oncology
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  193. Abstract 94952026-04-04 · 21:15 CT · S100A
    Tecentriq plus chemotherapy in previously untreated NSCLC: updated analysis from IMpower-140
    L. Paz-Ares, P. Schmid, C. Robert, et al. · Royal Marsden Hospital
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  194. Abstract 96862026-04-01 · 21:45 CT · S406
    Opdivo plus chemotherapy in previously untreated NSCLC: updated analysis from CheckMate-101
    M. Krop, M.C. Garassino, R. Herbst, et al. · University of Chicago
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  195. Abstract 95152026-04-01 · 20:30 CT · S100A
    Biomarker subgroup analysis of Enhertu in NSCLC (the DESTINY-Breast-318 study)
    S. Antonia, E. Winer · Stanford Cancer Institute
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  196. Abstract 99422026-04-02 · 16:00 CT · E450
    Long-term follow-up of Tecentriq 1L for NSCLC: IMpower-736
    J. Cortes, P. Schmid, H. Borghaei, et al. · Vall d'Hebron Institute of Oncology
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  197. Abstract 98742026-04-02 · 21:30 CT · S406
    Long-term follow-up of Tagrisso 2L for NSCLC: FLAURA-983
    S. Peters, G. Curigliano · Mayo Clinic
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  198. Abstract 97742026-04-05 · 13:45 CT · Arie Crown Theater
    Keytruda plus chemotherapy in previously untreated NSCLC: updated analysis from KEYNOTE-155
    S. Modi, S. Peters, S. Antonia, et al. · Peter MacCallum Cancer Centre
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  199. Abstract 95412026-04-05 · 18:15 CT · Arie Crown Theater
    Keytruda plus chemotherapy in previously untreated NSCLC: updated analysis from KEYNOTE-25
    J. Brahmer, M. Reck, S. Antonia, et al. · Princess Margaret Cancer Centre
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  200. Abstract 97212026-04-03 · 13:00 CT · Hall B1
    Long-term follow-up of Tagrisso maintenance for NSCLC: FLAURA-509
    S. Antonia, J. Brahmer, R. Herbst, et al. · Royal Marsden Hospital
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
© 2026 American Society of Clinical Oncology · Citations follow JCO supplement format:J Clin Oncol 44, 2026 (suppl 17; abstr XXXX). Demo mock.